Page 11234..1020..»

Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth – Singularity Hub

By daniellenierenberg

Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth  Singularity Hub

Read the original post:
Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth - Singularity Hub

To Read More: Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth – Singularity Hub
categoriaSkin Stem Cells commentoComments Off on Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth – Singularity Hub | dataMarch 18th, 2024
Read All

Vitamin A could have a key role in both stem cell biology and wound healing: Study – Medical Dialogues

By daniellenierenberg

Vitamin A could have a key role in both stem cell biology and wound healing: Study  Medical Dialogues

More here:
Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues

To Read More: Vitamin A could have a key role in both stem cell biology and wound healing: Study – Medical Dialogues
categoriaSkin Stem Cells commentoComments Off on Vitamin A could have a key role in both stem cell biology and wound healing: Study – Medical Dialogues | dataMarch 10th, 2024
Read All

A dive into the genetic history of India, and the role of vitamin A in skin repair – Science

By daniellenierenberg

A dive into the genetic history of India, and the role of vitamin A in skin repair  Science

Continue reading here:
A dive into the genetic history of India, and the role of vitamin A in skin repair - Science

To Read More: A dive into the genetic history of India, and the role of vitamin A in skin repair – Science
categoriaSkin Stem Cells commentoComments Off on A dive into the genetic history of India, and the role of vitamin A in skin repair – Science | dataMarch 10th, 2024
Read All

Herbosa: Clinic under probe after skin treatments linked to womans death – Philstar.com

By daniellenierenberg

Herbosa: Clinic under probe after skin treatments linked to womans death  Philstar.com

See the article here:
Herbosa: Clinic under probe after skin treatments linked to womans death - Philstar.com

To Read More: Herbosa: Clinic under probe after skin treatments linked to womans death – Philstar.com
categoriaSkin Stem Cells commentoComments Off on Herbosa: Clinic under probe after skin treatments linked to womans death – Philstar.com | dataJanuary 22nd, 2024
Read All

These Will Be the Biggest Skin-Care Trends of 2024 – Allure

By daniellenierenberg

These Will Be the Biggest Skin-Care Trends of 2024  Allure

Original post:
These Will Be the Biggest Skin-Care Trends of 2024 - Allure

To Read More: These Will Be the Biggest Skin-Care Trends of 2024 – Allure
categoriaSkin Stem Cells commentoComments Off on These Will Be the Biggest Skin-Care Trends of 2024 – Allure | dataDecember 28th, 2023
Read All

Sorry, But These 10 Skincare Products Are A Scam – Refinery29

By daniellenierenberg

Sorry, But These 10 Skincare Products Are A Scam  Refinery29

Read this article:
Sorry, But These 10 Skincare Products Are A Scam - Refinery29

To Read More: Sorry, But These 10 Skincare Products Are A Scam – Refinery29
categoriaSkin Stem Cells commentoComments Off on Sorry, But These 10 Skincare Products Are A Scam – Refinery29 | dataDecember 12th, 2023
Read All

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

By daniellenierenberg

- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in neurological and psychiatric disorders

The rest is here:
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

To Read More: Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
categoriaSkin Stem Cells commentoComments Off on Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator | dataDecember 4th, 2023
Read All

Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role

By daniellenierenberg

SAN DIEGO and TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced the appointment of Fletcher Payne to Chief Business Officer, in addition to his role as Senior Vice President, Chief Financial Officer.

Go here to read the rest:
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role

To Read More: Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
categoriaSkin Stem Cells commentoComments Off on Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role | dataDecember 4th, 2023
Read All

Opthea to Present at the FLORetina 2023 Congress

By daniellenierenberg

MELBOURNE, Australia, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced an oral presentation featuring sozinibercept (OPT-302) which will be presented at the annual FLORetina Congress being held November 30 to December 3, 2023, in Rome, Italy.

View post:
Opthea to Present at the FLORetina 2023 Congress

To Read More: Opthea to Present at the FLORetina 2023 Congress
categoriaSkin Stem Cells commentoComments Off on Opthea to Present at the FLORetina 2023 Congress | dataDecember 4th, 2023
Read All

HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses

By daniellenierenberg

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Nov. 30, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:?HCM; HKEX:?13) today highlights that new clinical data from several ongoing studies with HUTCHMED investigational drug candidates fruquintinib, surufatinib and HMPL-295, which will be presented at the upcoming European Society for Medical Oncology (“ESMO”) Asia Congress, taking place on December 1-3, 2023 in Singapore, and the ESMO Immuno-Oncology Congress, taking place on December 6-8, 2023 in Geneva, Switzerland.

See the rest here:
HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses

To Read More: HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses
categoriaSkin Stem Cells commentoComments Off on HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses | dataDecember 4th, 2023
Read All

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO

By daniellenierenberg

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO

See the article here:
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO

To Read More: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
categoriaSkin Stem Cells commentoComments Off on AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO | dataDecember 4th, 2023
Read All

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

By daniellenierenberg

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a transparency notification dated November 28, 2023, from Tolefi SA and related persons indicating that they have jointly crossed passively below the 15% threshold, holding 6,568,978 shares, or 14.997 % of the voting rights of the Company as of November 14, 2023.

Go here to see the original:
Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

To Read More: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
categoriaSkin Stem Cells commentoComments Off on Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007) | dataDecember 4th, 2023
Read All

Annovis Bio Appoints Andrew Walsh as Vice President Finance

By daniellenierenberg

BERWYN, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD) today announced the appointment of Andrew Walsh as VP, Finance.

Visit link:
Annovis Bio Appoints Andrew Walsh as Vice President Finance

To Read More: Annovis Bio Appoints Andrew Walsh as Vice President Finance
categoriaSkin Stem Cells commentoComments Off on Annovis Bio Appoints Andrew Walsh as Vice President Finance | dataDecember 4th, 2023
Read All

Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286, a Novel BRG1/BRM Inhibitor, in Patients with Advanced Hematologic…

By daniellenierenberg

CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that clinical data from the Phase 1 dose escalation study of FHD-286 in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) will be presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 9-12, 2023, in San Diego, California.

Read this article:
Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286, a Novel BRG1/BRM Inhibitor, in Patients with Advanced Hematologic...

To Read More: Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286, a Novel BRG1/BRM Inhibitor, in Patients with Advanced Hematologic…
categoriaSkin Stem Cells commentoComments Off on Foghorn Therapeutics Announces Clinical Data from Phase 1 Study of FHD-286, a Novel BRG1/BRM Inhibitor, in Patients with Advanced Hematologic… | dataDecember 4th, 2023
Read All

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

By daniellenierenberg

NEW YORK and BOSTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. to the Akari Board of Directors.

Continued here:
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

To Read More: Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
categoriaSkin Stem Cells commentoComments Off on Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors | dataDecember 4th, 2023
Read All

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

By daniellenierenberg

NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, today announced that five posters featuring data supporting its OV329 and OV350 programs for the potential treatment of epilepsies and treatment-resistant seizures will be presented at the 2023 American Epilepsy Society (AES) Annual Meeting in Orlando, Florida.

More:
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

To Read More: Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
categoriaSkin Stem Cells commentoComments Off on Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023) | dataDecember 4th, 2023
Read All

Spectral Medical Announces CFO Departure

By daniellenierenberg

TORONTO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that Blair McInnis has provided notice of his resignation as Chief Financial Officer of the Company, which is effective immediately, to pursue a new opportunity. Mr. McInnis will assist the Company to ensure a smooth transition.

Read the original here:
Spectral Medical Announces CFO Departure

To Read More: Spectral Medical Announces CFO Departure
categoriaSkin Stem Cells commentoComments Off on Spectral Medical Announces CFO Departure | dataDecember 4th, 2023
Read All

Are STEM CELL EXOSOMES the secret to a ‘snatched’ jawline? Discover the products that influencers are claiming – Daily Mail

By daniellenierenberg

Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming  Daily Mail

Excerpt from:
Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail

To Read More: Are STEM CELL EXOSOMES the secret to a ‘snatched’ jawline? Discover the products that influencers are claiming – Daily Mail
categoriaSkin Stem Cells commentoComments Off on Are STEM CELL EXOSOMES the secret to a ‘snatched’ jawline? Discover the products that influencers are claiming – Daily Mail | dataNovember 18th, 2023
Read All

Defence Mechanisms: Four ways your body is protecting you every time you fall sick – indulgexpress

By daniellenierenberg

Defence Mechanisms: Four ways your body is protecting you every time you fall sick  indulgexpress

See the rest here:
Defence Mechanisms: Four ways your body is protecting you every time you fall sick - indulgexpress

To Read More: Defence Mechanisms: Four ways your body is protecting you every time you fall sick – indulgexpress
categoriaSkin Stem Cells commentoComments Off on Defence Mechanisms: Four ways your body is protecting you every time you fall sick – indulgexpress | dataMay 16th, 2023
Read All

Treat Yourself to a Spa Day With a $100 Deal on $600 Worth of Products From Elemis, 111SKIN, Nest & More – E! NEWS

By daniellenierenberg

Treat Yourself to a Spa Day With a $100 Deal on $600 Worth of Products From Elemis, 111SKIN, Nest & More  E! NEWS

Read more from the original source:
Treat Yourself to a Spa Day With a $100 Deal on $600 Worth of Products From Elemis, 111SKIN, Nest & More - E! NEWS

To Read More: Treat Yourself to a Spa Day With a $100 Deal on $600 Worth of Products From Elemis, 111SKIN, Nest & More – E! NEWS
categoriaSkin Stem Cells commentoComments Off on Treat Yourself to a Spa Day With a $100 Deal on $600 Worth of Products From Elemis, 111SKIN, Nest & More – E! NEWS | dataMay 16th, 2023
Read All

Page 11234..1020..»


Copyright :: 2024